Biotech
TUSTIN, CA: 60% Improvement in Median Overall Survival in Patients Treated With Bavituximab Plus Docetaxel; Data Support Advancing Bavituximab Into Phase III Development ...
MONTREAL, CANADA: MONTREAL, CANADA -- (Marketwire) -- 02/19/13 -- ("MethylGene" or the "Company") (TSX: MYG) today announced that Mark J. Gergen has been appointed to the position of Executive Vic ...
MONTREAL, QUEBEC: MONTREAL, QUEBEC -- (Marketwire) -- 02/19/13 -- Alethia Biotherapeutics Inc., a privately held biotechnology company focusing on the development of therapeutic monoclonal antibodies, announced today ...
FORT WASHINGTON, PA and PALO ALTO, CA: The Partnership Offers a Turnkey Affiliation Data Management Application on the Reltio's Big Data Platform, and Is Fully Integrated With Healthcare Provider Data From AdvantageMS ...
LONDON and SOUTH SAN FRANCISCO, CA: LONDON and SOUTH SAN FRANCISCO, CA -- (Marketwire) -- 02/19/13 -- GlaxoSmithKline plc (LSE: GSK) and Theravance, Inc. (NASDAQ: THRX) today announced that the New Drug Application (NDA) for the invest ...
WINNIPEG, MANITOBA: WINNIPEG, MANITOBA -- (Marketwire) -- 02/19/13 -- Miraculins Inc. (TSX VENTURE: MOM), a medical diagnostic company focused on acquiring, developing and commercializing diagnostic tests and risk asse ...
MANCHESTER, UNITED KINGDOM: MANCHESTER, UNITED KINGDOM -- (Marketwire) -- 02/19/13 -- Epistem plc (LSE: EHP), the UK biotechnology and personalized medicine company, has announced today that their Contract Research Division� ...
BRISBANE, AUSTRALIA: BRISBANE, AUSTRALIA -- (Marketwire) -- 02/18/13 --Alchemia Limited (ASX: ACL) has recorded a quarterly profit share of $3.4 million on sales of its generic anti-coagulant product fondaparinux, an incr ...
BRISBANE, AUSTRALIA: BRISBANE, AUSTRALIA -- (Marketwire) -- 02/18/13 -- Brisbane drug discovery and development company Alchemia Limited (ASX: ACL) announced that Charles Walker has been appointed to the position of Chie ...
CALGARY, ALBERTA: CALGARY, ALBERTA -- (Marketwire) -- 02/15/13 -- Platino Energy Corp. ("Platino" or the "Company") (TSX VENTURE: PZE) has completed the transition of the responsibilities of the P ...
CARLSBAD, CA: CARLSBAD, CA -- (Marketwire) -- 02/15/13 -- International Stem Cell Corporation (OTCQB: ISCO) () ("ISCO" or "the Company"), a California-based biotechnology company, today announc ...
DUBAI, UNITED ARAB EMIRATES: New Non-Invasive Prenatal Test Now Available to Patients in the Middle East, Turkey, Africa, and Caspian Regions ...
TORONTO, ONTARIO: TORONTO, ONTARIO -- (Marketwire) -- 02/14/13 -- Solutions4CO2 Inc. ("S4CO2" or the "Company") (TSX VENTURE: SFC) is pleased to provide an update on the progress of its initiative ...
MONTREAL, QUEBEC: MONTREAL, QUEBEC -- (Marketwire) -- 02/14/13 -- Theratechnologies Inc. (TSX: TH) (Theratechnologies) announced today that it will issue its financial results for the fiscal year ended November 30, 2 ...
CHAPEL HILL, NC: CHAPEL HILL, NC -- (Marketwire) -- 02/14/13 -- (OTCQB: CWNM) is pleased to announce that Patents for its Controlled Drug Delivery Technology have been approved and registered in South Africa. Crown i ...
PORTLAND, ME: PORTLAND, ME -- (Marketwire) -- 02/14/13 -- (NASDAQ: ICCC) today announced the results of its operations for the three-month and twelve-month periods ended December 31, 2012."Despite the ongoing ...
VANCOUVER, BRITISH COLUMBIA: VANCOUVER, BRITISH COLUMBIA -- (Marketwire) -- 02/13/13 -- Calyx Bio-Ventures Inc. (TSX VENTURE: CYX) is pleased to announce that it has been recognized as a TSX Venture 50® company in 2013. The 20 ...
TUSTIN, CA: Top-Line Results Demonstrate Signs of Anti-Tumor Activity in Difficult to Treat Patient Population; Company Evaluating Next Steps for Advancing Bavituximab Pancreatic Program ...
SAN FRANCISCO, CA and TOKYO: Six Abstracts Presented Include Data from Phase II Study Investigating XTANDI(R) (enzalutamide) Capsules in Hormone-Naive Prostate Cancer ...
